Gene Name |
nuclear receptor subfamily 0, group B, member 1 |
estrogen receptor 2 (ER beta) |
Image |
No pdb structure |
|
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
- Diethylstilbestrol
- Raloxifene
- Tamoxifen
- Estradiol
- Trilostane
- Estramustine
- Genistein
- Para-Mercury-Benzenesulfonic Acid
- N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide
- 5-Alpha-Androstane-3-Beta,17beta-Diol
- 4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol
- Estriol
- Estropipate
- 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL
- 3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE
- [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE
- 4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL
- 2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL
- 2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL
- (3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol
- 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL
- 4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME
- 5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE
- 3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE
- 3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL
- (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL
- (16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL
- (9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one
- (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL
- (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL
|
Diseases |
|
|
GWAS |
|
|
Protein-Protein Interactions |
16 interactors:
AR
COPS2
ESR1
ESR2
ESRRA
ESRRG
NR3C1
NR5A1
NRIP1
PGR
POU5F1
PPARG
RNF31
RORA
SNW1
SREBF1
|
88 interactors:
AKAP13
AKT1
ARID5A
BCAS2
CALM1
CALM2
CALM3
CCNC
CDK8
DAP3
DDX17
DDX5
DDX54
DNTTIP2
EIF3I
EP300
ESR1
JMJD1C
KAT5
LCK
MAD2L1
MAPK1
MAPK11
MED1
MED10
MED12
MED14
MED16
MED17
MED20
MED21
MED23
MED24
MED6
MED7
MEOX2
MKNK2
MMS19
MSH2
NCOA1
NCOA2
NCOA3
NCOA6
NCOA7
NCOR1
NCOR2
NFKBIB
NOTCH2NL
NR0B1
NR0B2
NRIP1
OXT
PELP1
PIAS1
PIAS2
PIAS3
PLSCR1
PNRC1
PNRC2
PPARG
PPARGC1A
PPP5C
PRMT2
PSMC3IP
RBFOX2
RBM39
REXO4
RFX6
RXRA
SERPINH1
SMAD2
SMAD3
SMAD4
SMARCE1
SP1
SRA1
SRC
SREBF1
STAT5A
TRAM1
TRIM24
TRIM59
TRIP4
WIPI1
YWHAH
YWHAQ
ZBTB17
ZNHIT3
|
Entrez ID |
190 |
2100 |
HPRD ID |
08362 |
03390 |
Ensembl ID |
|
ENSG00000140009
|
Uniprot IDs |
F1D8P4
P51843
|
F1D8N3
G3V5M5
Q0PTK2
Q7LCB3
Q92731
|
PDB IDs |
|
1L2J
1NDE
1QKM
1U3Q
1U3R
1U3S
1U9E
1X76
1X78
1X7B
1X7J
1YY4
1YYE
1ZAF
2FSZ
2GIU
2I0G
2JJ3
2NV7
2QTU
2YJD
2YLY
2Z4B
3OLL
3OLS
3OMO
3OMP
3OMQ
4J24
4J26
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
always
cd99
chondrosarcoma
comprising
differentiate
diffuse
e2f3
es
ewing
ewsr1
exceptional
extraskeletal
fli1
gold
immunohistochemical
marker
merkel
mesenchymal
myxoid
neoplasm
neuroblastomas
nkx2
olfactory
powerful
reinforces
round
sarcoma
singly
srcts
|
25mg
acrosomes
bisphenol
bpa
compromises
disrupts
dosages
epididymis
esr1
fsh
fshb
gnrhr
gonadal
gonadotropin
hypogonadism
hypogonadotropic
hypothalamic
lh
lhb
luteinizing
nontoxic
pituitary
reestablish
reproductive
reserves
sperm
spermatogenesis
spermatozoa
transit
|
Tagcloud (Difference) ? |
always
cd99
chondrosarcoma
comprising
differentiate
diffuse
e2f3
es
ewing
ewsr1
exceptional
extraskeletal
fli1
gold
immunohistochemical
marker
merkel
mesenchymal
myxoid
neoplasm
neuroblastomas
nkx2
olfactory
powerful
reinforces
round
sarcoma
singly
srcts
|
25mg
acrosomes
bisphenol
bpa
compromises
disrupts
dosages
epididymis
esr1
fsh
fshb
gnrhr
gonadal
gonadotropin
hypogonadism
hypogonadotropic
hypothalamic
lh
lhb
luteinizing
nontoxic
pituitary
reestablish
reproductive
reserves
sperm
spermatogenesis
spermatozoa
transit
|
Tagcloud (Intersection) ? |
|